Stock 4119 SCI PHARMTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SCI Pharmtech, Inc.

Equities

4119

TW0004119003

Pharmaceuticals

End-of-day quote Taiwan S.E.
Other stock markets
 18:00:00 2024-05-06 EDT 		5-day change 1st Jan Change
88.1 TWD -0.45% Intraday chart for SCI Pharmtech, Inc. -1.01% -8.99%
03-20 SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,620 8,454 6,677 8,012 9,300 11,568
Enterprise Value (EV) 1 4,828 7,438 6,046 7,322 9,581 11,580
P/E ratio 12.7 x 15.3 x 18.7 x 145 x 30.2 x 36 x
Yield 5.94% 5.32% 0.6% - 0.26% 1.29%
Capitalization / Revenue 2.9 x 3.59 x 2.48 x 9.27 x 10.3 x 9.61 x
EV / Revenue 2.49 x 3.16 x 2.25 x 8.47 x 10.6 x 9.62 x
EV / EBITDA 7.45 x 8.94 x 5.11 x 54 x 46.1 x 38.1 x
EV / FCF 18.7 x 18.9 x 8.15 x -16 x -8.22 x -9.67 x
FCF Yield 5.36% 5.28% 12.3% -6.26% -12.2% -10.3%
Price to Book 1.75 x 2.49 x 2.01 x 2.41 x 2.56 x 2.27 x
Nbr of stocks (in thousands) 107,305 104,708 107,305 107,305 107,305 119,509
Reference price 2 52.37 80.74 62.22 74.67 86.67 96.80
Announcement Date 19-03-15 20-03-16 21-03-26 22-03-22 23-03-21 24-03-20
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,940 2,356 2,689 864.2 899.7 1,204
EBITDA 1 648 831.9 1,183 135.6 207.9 303.7
EBIT 1 515.6 697.1 1,052 73.66 119 160.3
Operating Margin 26.58% 29.59% 39.1% 8.52% 13.22% 13.31%
Earnings before Tax (EBT) 1 544.8 711.2 455.2 65.51 387.8 364.2
Net income 1 447.2 571.1 360.1 55.7 308.8 294.7
Net margin 23.05% 24.24% 13.39% 6.44% 34.32% 24.48%
EPS 2 4.126 5.274 3.326 0.5156 2.871 2.690
Free Cash Flow 1 258.6 392.9 741.9 -458.7 -1,165 -1,198
FCF margin 13.33% 16.68% 27.59% -53.07% -129.54% -99.47%
FCF Conversion (EBITDA) 39.91% 47.22% 62.72% - - -
FCF Conversion (Net income) 57.83% 68.79% 206% - - -
Dividend per Share 2 3.111 4.296 0.3704 - 0.2222 1.250
Announcement Date 19-03-15 20-03-16 21-03-26 22-03-22 23-03-21 24-03-20
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 228.3 135.8 188 181.4 304.6 225.8 341.8
EBITDA - - - - - - -
EBIT 1 36.79 -25.89 18.23 15.38 47.14 38.23 78.78
Operating Margin 16.12% -19.07% 9.69% 8.48% 15.48% 16.93% 23.05%
Earnings before Tax (EBT) 1 37.04 -27.91 52.01 176 62.3 97.5 78.72
Net income 1 29.92 -19.65 41.17 140.3 48.62 78.65 63.44
Net margin 13.11% -14.47% 21.9% 77.38% 15.96% 34.84% 18.56%
EPS 2 0.2756 -0.1867 0.3822 1.307 0.4533 0.7289 0.5867
Dividend per Share - - - - - - -
Announcement Date 22-01-17 22-03-18 22-05-06 22-08-11 22-11-11 23-03-21 23-05-15
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 281 11.4
Net Cash position 1 791 1,017 630 690 - -
Leverage (Debt/EBITDA) - - - - 1.351 x 0.0376 x
Free Cash Flow 1 259 393 742 -459 -1,165 -1,198
ROE (net income / shareholders' equity) 14.6% 17.1% 10.6% 1.68% 8.89% 6.75%
ROA (Net income/ Total Assets) 9.1% 11.1% 15.2% 1.05% 1.63% 1.72%
Assets 1 4,917 5,158 2,370 5,299 19,001 17,138
Book Value Per Share 2 29.90 32.40 31.00 30.90 33.80 42.70
Cash Flow per Share 2 3.370 5.160 5.900 3.100 1.550 7.880
Capex 1 147 200 218 771 1,168 1,029
Capex / Sales 7.57% 8.47% 8.1% 89.22% 129.77% 85.48%
Announcement Date 19-03-15 20-03-16 21-03-26 22-03-22 23-03-21 24-03-20
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
SCI PHARMTECH, INC. Stock SCI Pharmtech, Inc.
-8.99% 325M
MERCK KGAA Stock Merck KGaA
+7.84% 71.94B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.16% 9.27B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-11.55% 5.13B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+48.05% 4.66B
YUHAN CORPORATION Stock Yuhan Corporation
+5.09% 3.97B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-14.74% 2.55B
INDIVIOR PLC Stock Indivior PLC
+19.16% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-24.89% 2.36B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+21.45% 2.21B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4119 Stock
  4. Financials SCI Pharmtech, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW